Anthracycline Antibiotics

Anthracycline antibiotics are a class of cytotoxic antineoplastic agents originally derived from *Streptomyces* bacteria This class, which includes agents such as doxorubicin, daunorubicin, and epirubicin, serves a vital role in oncology regimens for treating both hematologic malignancies, such as leukemias and lymphomas, and various solid tumors, including breast cancer and sarcomas

Anthracycline antibiotics are a class of cytotoxic antineoplastic agents originally derived from *Streptomyces* bacteria This class, which includes agents such as doxorubicin, daunorubicin, and epirubicin, serves a vital role in oncology regimens for treating both hematologic malignancies, such as leukemias and lymphomas, and various solid tumors, including breast cancer and sarcomas

Anthracycline antibiotics are a class of cytotoxic antineoplastic agents originally derived from *Streptomyces* bacteria They exert their therapeutic effects primarily by intercalating into cellular DNA, inhibiting the enzyme topoisomerase II to induce double-stranded DNA breaks, and generating cytotoxic reactive oxygen species that disrupt nucleic acid and protein synthesis

They exert their therapeutic effects primarily by intercalating into cellular DNA, inhibiting the enzyme topoisomerase II to induce double-stranded DNA breaks, and generating cytotoxic reactive oxygen species that disrupt nucleic acid and protein synthesis

This class, which includes agents such as doxorubicin, daunorubicin, and epirubicin, serves a vital role in oncology regimens for treating both hematologic malignancies, such as leukemias and lymphomas, and various solid tumors, including breast cancer and sarcomas